Anthracycline-Induced Cardiomyopathy-Reference-Cited by-同舟云学术

Anthracycline-Induced Cardiomyopathy

Published:2010-01 Issue:3 Volume:55 Page:213-220
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cardinale Daniela,Colombo Alessandro,Lamantia Giuseppina,Colombo Nicola,Civelli Maurizio,De Giacomi Gaia,Rubino Mara,Veglia Fabrizio,Fiorentini Cesare,Cipolla Carlo M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Cardiotoxicity of chemotherapeutic agents;Pai;Drug Safety,2000

2. Cardiovascular complications of cancer therapy;Yeh;Circulation,2004

3. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy;Felker;N Engl J Med,2000

4. Relation between gender, etiology and survival in patients with symptomatic heart failure;Adams;J Am Coll Cardiol,1996

5. Cardiac toxicity 4 to 20 years after completing anthracyline therapy;Steinherz;JAMA,1991

Cited by 924 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents;Current Protein & Peptide Science;2024-12

2. Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury;Cardiovascular Pathology;2024-11

3. Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer;Journal of Cardiology;2024-10

4. Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial;European Heart Journal;2024-09-01

5. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials;European Journal of Internal Medicine;2024-08